Table 4 Correlation of study variables and the conclusions drawn
From: Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
S No | Pearson corelation coefficient | Variables | Conclusion |
|---|---|---|---|
1 | 0.99593036 | Intraretinal cystic space appearance and administration of injection | Very strong positive correlation; almost perfect linear relationship |
2 | 0.374265823 | Neurosensory detachment appearance and administration of injection | Moderate positive correlation; significant linear relationship |
3 | 0.299495663 | Appearance of traction on OCT and administration of injection | Moderate positive correlation; some linear relationship |
4 | 0.18688659 | Occurrence of side effects i and administration of injection | Weak positive correlation; slight linear relationship |
5 | 0.770028998 | BCVA LogMAR value and administration of injection | Strong positive correlation; strong linear relationship |
6 | 0.803219329 | Central macular thickness on OCT and administration of injection | Strong positive correlation; strong linear relationship |
7 | − 0.770993337 | Absolute Contrast value and administration of injection | Strong negative correlation; strong inverse linear relationship |
8 | 0.917108963 | BCVA LogMAR value and CMT on OCT | Very strong positive correlation; very strong linear relationship |
9 | − 0.897550295 | BCVA LogMAR value and & Absolute Contrast value | Very strong negative correlation; very strong inverse linear relationship |
10 | − 0.832077573 | Absolute Contrast value & CMT on OCT | Strong negative correlation; strong inverse linear relationship |